home / stock / inrlf / inrlf short
Short Information | Valneva Se Ord (OTCMKTS:INRLF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 9,162 |
Total Actual Volume | 15,816 |
Short Trends | |
---|---|
Cover Days | 6 |
Short Days | 14 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 458 |
Average Short Percentage | 66.82% |
Is there a INRLF Short Squeeze or Breakout about to happen?
See the INRLF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-11-2024 | $4.25 | $4.25 | $4.25 | $4.25 | 1,965 | 1,965 | 100% |
03-12-2024 | $3.863 | $3.863 | $3.863 | $3.863 | 250 | 250 | 100% |
03-11-2024 | $3.6 | $3.7 | $3.7 | $3.6 | 1,325 | 1,000 | 75.47% |
03-08-2024 | $3.75 | $3.75 | $3.75 | $3.75 | 1,002 | 1,002 | 100% |
03-06-2024 | $0 | $3.47 | $0 | $0 | 75 | 75 | 100% |
03-04-2024 | $3.47 | $3.47 | $3.47 | $3.47 | 100 | 100 | 100% |
02-21-2024 | $3.55 | $3.55 | $3.55 | $3.55 | 1,030 | 1,000 | 97.09% |
02-20-2024 | $3.75 | $3.5 | $3.75 | $3.5 | 585 | 150 | 25.64% |
02-09-2024 | $3.99 | $3.84 | $3.99 | $3.84 | 200 | 100 | 50% |
02-06-2024 | $4.25 | $4.25 | $4.25 | $4.25 | 820 | 820 | 100% |
02-05-2024 | $3.87 | $3.77 | $4 | $3.77 | 2,200 | 400 | 18.18% |
01-26-2024 | $4.2 | $4.2 | $4.2 | $4.2 | 320 | 320 | 100% |
01-25-2024 | $4.1 | $4.01 | $4.1 | $4.01 | 3,015 | 1,015 | 33.67% |
01-17-2024 | $0 | $5.4 | $0 | $0 | 15 | 15 | 100% |
01-03-2024 | $5.0896 | $5.0896 | $5.0896 | $5.0896 | 660 | 10 | 1.52% |
12-27-2023 | $5.33 | $5.2975 | $5.33 | $5.2975 | 600 | 300 | 50% |
12-08-2023 | $5.45 | $5.45 | $5.45 | $5.45 | 230 | 230 | 100% |
11-13-2023 | $6.89 | $6.89 | $6.89 | $6.89 | 141 | 10 | 7.09% |
11-10-2023 | $6.89 | $6.85 | $6.89 | $6.85 | 200 | 100 | 50% |
10-25-2023 | $5.69 | $5.55 | $5.81 | $5.55 | 1,083 | 300 | 27.7% |
News, Short Squeeze, Breakout and More Instantly...
Valneva Se Ord Company Name:
INRLF Stock Symbol:
OTCMKTS Market:
Saint-Herblain (France), March 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the initiation of a Phase 1 clinical trial to investigate the the safety and immunogenicity of VLA1601, its second-generation adjuvanted inac...
Saint-Herblain (France), March 25, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 22, 2024, of its 2023 Universal Registration Document (URD) with the French Financial Markets Authority (AMF) under the filing n...
Saint-Herblain (France), March 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it will present on its single-shot chikungunya vaccine, IXCHIQ ® , moderate a roundtable on the Zika and chikungunya viruses, and partic...